Ophidian,
I was not doubting AffyXell as a credible Avacta product, just that a Korean website that goes down quickly and the home page in Korean all seems a bit unauthentic, but lets hope my cynicism is unfounded and we get some near term news!
Gmcc, AS cannot say anything new or price sensitive at next weeks investor meetings without informing the market first! They must be making a big play, presumably on Av6000 progress/ results to date, to justify 3 days of presentations to some big IIās !
So I fully expect an RNS to update the market late this week or 31st.
I am fully expecting the trading update to be next week and with it a technical & commercial update regarding both Ava6000 and LFT (hopefully tweak fixed!?), together with an AS statement that not only says that is he very pleased with Ava6000 progress. but this is also a major inflexion point for the company! IMHO
"Does anyone know when first report of data on AVA6000, or 2021 financials are expected?"
Surprised that they have not announced when this will be, but has to now be next week before the road show on 1-4th Feb, also maybe a bit delayed to ensure that maximum info can be included, as I expect a business update with the financials.
I think the market is looking for more detail on Ava6000 results (rather than inference from an announcement of an associated drug program) to get real buying going, and of course resolution of the Affidx saga! Both should be updated in next 2 weeks, imho.
Mario,
The 228 p price is based on zero for Affidx and a 10% chance of success of Av6000!
, that is as of what was known last week. So when the new LFT is on the market and the Av6000 results are made public in the next 2-3 weeks then the new broker assessment of the sp will be more like Ā£5!
TK,
The sp will respond as soon as AS says the new LFT has been fixed and validated by Abdx manufacture test run and is thus available to the market, sales will follow later and will further enhance the sp.
The current value of any company is the sp times no. of shares in issue. So that could be anything as the sp is generally driven by emotion and sentiment (not high for Avacta at the moment!) and not by its intrinsic value or asset value. Its asset value is what the Brokers notes try to assess valuing on a NPV/risk basis. The sp would be expected to reflect the asset value in a stable/fair market, however as said before its driven by sentiment in an unstable market (due to lack of real news that is eagerly awaited here) here at the moment.
You can just put it down to the MM's, they are looking for a trade (buy or sell) in order to make money (their cut), so if the volume is low they drop the sp to entice buyers and raise the sp when buyers come in, if no sustained buying (usually only on news) then the drop the sp down again, rinse n repeat. It has nothing to do with the underlying value of the shares, only a daily churn (when there is no news/vclear direction) to create some income for them!